← Evidence map

ArticleIndian journal of pharmacology

Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Almesh Kadakol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
2025
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 29515275